Through its Apsis affiliate in France, Johnson & Johnson Medical Devices is acquiring Orthotaxy, developer of a robotic-assisted surgery solution in early-stage development for total and partial knee replacement.
Orthotaxy was founded by robotics entrepreneur Stéphane Lavallée, Ph.D., whose numerous granted and pending patents address all manner of surgical enabling technologies and whose Surgivisio company is a first-time exhibitor at AAOS 2018.
Orthotaxy's software-enabled technology will join JNJ's present toolbox for delivery of personalized approaches across an episode of care, with offerings like DePuy Synthes' TRUMATCH personalized cuttting guides for the knee; Health Partner to support behavioral change in joint replacement patients pre- and post-op; delivery of care services for healthcare systems, like CareAdvantage and the Orthopaedic Episode of Care Approach; 3D printing technology acquired from Tissue Regeneration Systems, etc.
JNJ seeks to expand into a range of orthopaedic applications with a differentiated offering that is cost-effective, efficient and useful across a variety of care settings. We're eager to see the first iterations and learn how the system might compete against Stryker's Mako system.
Sources: Johnson & Johnson Medical Devices Companies; ORTHOWORLD Inc.